344 related articles for article (PubMed ID: 35056661)
1. Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor Development.
Dana D; Das T; Choi A; Bhuiyan AI; Das TK; Talele TT; Pathak SK
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056661
[TBL] [Abstract][Full Text] [Related]
2. Targeting NEK2 as a promising therapeutic approach for cancer treatment.
Fang Y; Zhang X
Cell Cycle; 2016; 15(7):895-907. PubMed ID: 27019372
[TBL] [Abstract][Full Text] [Related]
3. The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cells.
Rivera-Rivera Y; Marina M; Jusino S; Lee M; Velázquez JV; Chardón-Colón C; Vargas G; Padmanabhan J; Chellappan SP; Saavedra HI
Sci Rep; 2021 Apr; 11(1):9016. PubMed ID: 33907253
[TBL] [Abstract][Full Text] [Related]
4. Nek2 kinase in chromosome instability and cancer.
Hayward DG; Fry AM
Cancer Lett; 2006 Jun; 237(2):155-66. PubMed ID: 16084011
[TBL] [Abstract][Full Text] [Related]
5. Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.
Wu SM; Lin SL; Lee KY; Chuang HC; Feng PH; Cheng WL; Liao CJ; Chi HC; Lin YH; Tsai CY; Chen WJ; Yeh CT; Lin KH
Int J Cancer; 2017 Apr; 140(7):1581-1596. PubMed ID: 27925179
[TBL] [Abstract][Full Text] [Related]
6. LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance.
Roberts MS; Sahni JM; Schrock MS; Piemonte KM; Weber-Bonk KL; Seachrist DD; Avril S; Anstine LJ; Singh S; Sizemore ST; Varadan V; Summers MK; Keri RA
Cancer Res; 2020 Apr; 80(8):1693-1706. PubMed ID: 32054769
[TBL] [Abstract][Full Text] [Related]
7. Role of NIMA-related kinase 2 in lung cancer: Mechanisms and therapeutic prospects.
Shah D; Joshi M; Patel BM
Fundam Clin Pharmacol; 2022 Oct; 36(5):766-776. PubMed ID: 35338518
[TBL] [Abstract][Full Text] [Related]
8. Preclinical activity of MBM-5 in gastrointestinal cancer by inhibiting NEK2 kinase activity.
Fang Y; Kong Y; Xi J; Zhu M; Zhu T; Jiang T; Hu W; Ma M; Zhang X
Oncotarget; 2016 Nov; 7(48):79327-79341. PubMed ID: 27764815
[TBL] [Abstract][Full Text] [Related]
9. Identification by high-throughput screening of viridin analogs as biochemical and cell-based inhibitors of the cell cycle-regulated nek2 kinase.
Hayward DG; Newbatt Y; Pickard L; Byrne E; Mao G; Burns S; Sahota NK; Workman P; Collins I; Aherne W; Fry AM
J Biomol Screen; 2010 Sep; 15(8):918-927. PubMed ID: 20664067
[TBL] [Abstract][Full Text] [Related]
10. NEK2 Is an Effective Target for Cancer Therapy With Potential to Induce Regression of Multiple Human Malignancies.
Kokuryo T; Yokoyama Y; Yamaguchi J; Tsunoda N; Ebata T; Nagino M
Anticancer Res; 2019 May; 39(5):2251-2258. PubMed ID: 31092416
[TBL] [Abstract][Full Text] [Related]
11. Dynamic recruitment of Nek2 kinase to the centrosome involves microtubules, PCM-1, and localized proteasomal degradation.
Hames RS; Crookes RE; Straatman KR; Merdes A; Hayes MJ; Faragher AJ; Fry AM
Mol Biol Cell; 2005 Apr; 16(4):1711-24. PubMed ID: 15659651
[TBL] [Abstract][Full Text] [Related]
12. Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma.
Franqui-Machin R; Hao M; Bai H; Gu Z; Zhan X; Habelhah H; Jethava Y; Qiu L; Frech I; Tricot G; Zhan F
J Clin Invest; 2018 Jul; 128(7):2877-2893. PubMed ID: 29863498
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of the mitotic regulator protein Hec1 by Nek2 kinase is essential for faithful chromosome segregation.
Chen Y; Riley DJ; Zheng L; Chen PL; Lee WH
J Biol Chem; 2002 Dec; 277(51):49408-16. PubMed ID: 12386167
[TBL] [Abstract][Full Text] [Related]
14. Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells.
Ghaleb A; Padellan M; Marchenko N
Breast Cancer Res; 2020 Dec; 22(1):133. PubMed ID: 33267874
[TBL] [Abstract][Full Text] [Related]
15. Nek2 phosphorylates and stabilizes β-catenin at mitotic centrosomes downstream of Plk1.
Mbom BC; Siemers KA; Ostrowski MA; Nelson WJ; Barth AI
Mol Biol Cell; 2014 Apr; 25(7):977-91. PubMed ID: 24501426
[TBL] [Abstract][Full Text] [Related]
16. A centrosomal function for the human Nek2 protein kinase, a member of the NIMA family of cell cycle regulators.
Fry AM; Meraldi P; Nigg EA
EMBO J; 1998 Jan; 17(2):470-81. PubMed ID: 9430639
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor-2 regulates protein phosphatase-1 complexed with NimA-related kinase to induce centrosome separation.
Eto M; Elliott E; Prickett TD; Brautigan DL
J Biol Chem; 2002 Nov; 277(46):44013-20. PubMed ID: 12221103
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel spirocyclic Nek2 inhibitor using high throughput virtual screening.
Bhuiyan AI; Choi AH; Ghoshal S; Adiele UA; Dana D; Choi JY; Fath KR; Talele TT; Pathak SK
Bioorg Med Chem Lett; 2023 May; 88():129288. PubMed ID: 37094724
[TBL] [Abstract][Full Text] [Related]
19. C-Nap1, a novel centrosomal coiled-coil protein and candidate substrate of the cell cycle-regulated protein kinase Nek2.
Fry AM; Mayor T; Meraldi P; Stierhof YD; Tanaka K; Nigg EA
J Cell Biol; 1998 Jun; 141(7):1563-74. PubMed ID: 9647649
[TBL] [Abstract][Full Text] [Related]
20. beta-Catenin is a Nek2 substrate involved in centrosome separation.
Bahmanyar S; Kaplan DD; Deluca JG; Giddings TH; O'Toole ET; Winey M; Salmon ED; Casey PJ; Nelson WJ; Barth AI
Genes Dev; 2008 Jan; 22(1):91-105. PubMed ID: 18086858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
